The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Many people with depression are treated with a serotonin-specific reuptake inhibitor
anti-depressant (SSRI) and feel 'better'. Although many people feel 'better', they do not
feel completely 'well'. Often, individuals continue to complain of cognitive problems such as
lack of attention, diminished motivation, and impaired problem-solving. This study looks at
whether residual and cognitive symptoms of depression in individuals are affected by the
addition of Wellbutrin (bupropion).
Phase:
Phase 3
Details
Lead Sponsor:
Mclean Hospital
Collaborator:
National Association for Research on Schizophrenia and Affective Disorders.